×

Error message

  • Failed to authorize with Brightcove
  • Failed to authorize with Brightcove
  • Failed to authorize with Brightcove
News | August 07, 2012

Elekta and Brainlab Collaborate to Increase Accuracy and Comfort of Radiosurgery Treatments

August 7, 2012 —Brainlab and Elekta have announced the first installation of an Elekta linear accelerator (linac) equipped with the ExacTrac patient positioning system by Brainlab; a strategy to make radiosurgery treatments for cancer patients more accurate and comfortable. ExacTrac is planned to be integrated with a total of two Elekta linacs at Fortis Memorial Research Institute in Gurgaon, India.

"ExacTrac is a highly accurate, intuitive and fast IGRT (image-guided radiation therapy) system and, in combination with our advanced Elekta treatment system, gives us the opportunity to maximize the benefits of both systems for our patients," said Dr. Ashok V. Chordiya, zonal director, Fortis Memorial Research Institute, Gurgaon.

With more than 500 installations worldwide, ExacTrac is a field-proven system for supporting sub-millimetric patient positioning for patients with tumors anywhere in the brain and body. The system offers a valuable solution, known as frameless radiosurgery. ExacTrac helps to reduce errors within the treatment process and potentially maximize overall accuracy.

"In our search to advance the accessibility to high precision treatment alternatives that are less invasive, we required collaboration with an equally dedicated partner," said Thomas Kraft, president RoW/Japan, Brainlab. "In Elekta, we found such a partner, and one with a highly regarded, advanced treatment platform. Together we will continue to strive for optimal efficiency, integrated workflow and improved patient care."

"We believe that technology should be based on open interfaces and industry standards, since hospitals use different kinds of technical solutions. ExacTrac will give customers the freedom to choose a solution that best meets their unique workflow and patient care needs. The stereotactic workflow between both systems allows an accurate and fast workflow for patient positioning,” added Bill Yaeger, executive vice president of Elekta Oncology.

Fortis Healthcare Ltd., with an asset base spanning ten countries, is an integrated healthcare provider in the Pan Asia-Pacific region.

For more information: www.brainlab.com, www.elekta.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init